Debra Odink
2011
In 2011, Debra Odink earned a total compensation of $622.4K as Chief Technology Officer at Anthera Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $30,070 |
|---|---|
| Option Awards | $278,198 |
| Salary | $269,000 |
| Stock Awards | $45,104 |
| Total | $622,372 |
Odink received $278.2K in option awards, accounting for 45% of the total pay in 2011.
Odink also received $30.1K in non-equity incentive plan, $269K in salary and $45.1K in stock awards.
Rankings
In 2011, Debra Odink's compensation ranked 7,362nd out of 10,747 executives tracked by ExecPay. In other words, Odink earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,362 out of 10,747 | 32nd |
Division Manufacturing | 2,691 out of 3,960 | 32nd |
Major group Chemicals And Allied Products | 660 out of 1,033 | 36th |
Industry group Drugs | 459 out of 781 | 41st |
Industry Pharmaceutical Preparations | 354 out of 571 | 38th |
Source: SEC filing on April 28, 2014.
Odink's colleagues
We found five more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2011.
2011
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2011
Christopher Lowe
Anthera Pharmaceuticals
Chief Financial Officer
2011
Colin Hislop
Anthera Pharmaceuticals
Chief Medical Officer
2011
Georgina Kilfoil
Anthera Pharmaceuticals
Senior Vice President, Product Development
2011
May Liu
Anthera Pharmaceuticals